rs115965425
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_173551.5(ANKS6):c.862+20G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00117 in 1,537,674 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0064 ( 9 hom., cov: 32)
Exomes 𝑓: 0.00059 ( 6 hom. )
Consequence
ANKS6
NM_173551.5 intron
NM_173551.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.274
Publications
1 publications found
Genes affected
ANKS6 (HGNC:26724): (ankyrin repeat and sterile alpha motif domain containing 6) This gene encodes a protein containing multiple ankyrin repeats and a SAM domain. It is thought that this protein may localize to the proximal region of the primary cilium, and may play a role in renal and cardiovascular development. Mutations in this gene have been shown to cause a form of nephronophthisis (NPHP16), a chronic tubulo-interstitial nephritis. [provided by RefSeq, Jul 2015]
ANKS6 Gene-Disease associations (from GenCC):
- nephronophthisis 16Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
- nephronophthisis 1Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- nephronophthisis 2Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BP6
Variant 9-98790084-C-T is Benign according to our data. Variant chr9-98790084-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262857.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00643 (979/152308) while in subpopulation AFR AF = 0.0221 (918/41552). AF 95% confidence interval is 0.0209. There are 9 homozygotes in GnomAd4. There are 490 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00642 AC: 977AN: 152190Hom.: 9 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
977
AN:
152190
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00196 AC: 391AN: 199334 AF XY: 0.00159 show subpopulations
GnomAD2 exomes
AF:
AC:
391
AN:
199334
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000590 AC: 817AN: 1385366Hom.: 6 Cov.: 31 AF XY: 0.000554 AC XY: 376AN XY: 678196 show subpopulations
GnomAD4 exome
AF:
AC:
817
AN:
1385366
Hom.:
Cov.:
31
AF XY:
AC XY:
376
AN XY:
678196
show subpopulations
African (AFR)
AF:
AC:
635
AN:
31666
American (AMR)
AF:
AC:
64
AN:
36602
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
21406
East Asian (EAS)
AF:
AC:
2
AN:
38654
South Asian (SAS)
AF:
AC:
8
AN:
75776
European-Finnish (FIN)
AF:
AC:
0
AN:
50608
Middle Eastern (MID)
AF:
AC:
0
AN:
5284
European-Non Finnish (NFE)
AF:
AC:
22
AN:
1068328
Other (OTH)
AF:
AC:
86
AN:
57042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
47
94
142
189
236
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00643 AC: 979AN: 152308Hom.: 9 Cov.: 32 AF XY: 0.00658 AC XY: 490AN XY: 74472 show subpopulations
GnomAD4 genome
AF:
AC:
979
AN:
152308
Hom.:
Cov.:
32
AF XY:
AC XY:
490
AN XY:
74472
show subpopulations
African (AFR)
AF:
AC:
918
AN:
41552
American (AMR)
AF:
AC:
40
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
1
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4
AN:
68028
Other (OTH)
AF:
AC:
15
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
49
98
148
197
246
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Nephronophthisis 16 Benign:2
Jul 26, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.